Alyson Moadel Discusses Partner-Related Prostate Cancer Side Effects

Video

Alyson Moadel, PhD, director of psychosocial oncology, Albert Einstein College of Medicine, Montefiore Medical Center, discusses partner-related side effects of prostate cancer.

Alyson Moadel, PhD, director of psychosocial oncology, Albert Einstein College of Medicine, Montefiore Medical Center, discusses partner-related side effects of prostate cancer.

Patients with prostate cancer not only experience side effects such as urinary incontinence, but also issues with their sexuality and body image and performance. These are often very frustrating for patients, and must be addressed with the patient, his partner and the healthcare team.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
2 experts are featured in this series.
Image of a woman with shoulder-length black hair wearing headphones and a white sweater
Related Content
Blue image of kidneys with renal tubules highlighted in red

Nivolumab Plus Cabozantinib Effective Long-Term for Advanced RCC

Tim Cortese
February 15th 2025
Article

Patients with advanced RCC who were treated with nivolumab plus cabozantinib had a median PFS of 16.4 months compared with 8.3 months from sunitinib alone.

Oncology Nursing News

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News
January 2nd 2023
Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Graphic of care providers, patients, and families conversing near large computers and health charts

Digital Health Tool Helps Patients With Prostate Cancer During Consultations

Bridget Hoyt
February 14th 2025
Article

MyCareGorithm was met with high approval from patients, companions, and physicians, with all 3 groups reporting they’d recommend the tool to other patients.

Oncology Nursing Stories: Acupuncture Helps Thyroid Cancer Survivor Taper Opioid Use

Oncology Nursing Stories: Acupuncture Helps Thyroid Cancer Survivor Taper Opioid Use

Lindsay Fischer
December 15th 2022
Podcast

In this episode of "The Vitals," Heather Jackson, PhD, FNP-BC, NEA-BC, FAANP, shares her experience helping a patient reduce their opioid use through acupuncture treatments.

Rendering of prostate cancer cells

Clinical Practice Gaps Persist in Biomarker Testing for mCRPC Management

Darlene Dobkowski, MA
February 13th 2025
Article

With delays in biomarker testing and treatment for metastatic castration-resistant prostate cancer, continued education is needed to address these gaps.

Rendering of a bladder and prostate, surrounded by images of cancerous cells

Talazoparib-Enzalutamide Combo Increases OS in mCRPC

Jordyn Sava
February 13th 2025
Article

Patients with HRR-deficient metastatic castration-resistant prostate cancer saw a 14-month boost in OS and a 38% lower risk of death with talazoparib plus enzalutamide.